News

Neuronetics' NeuroStar® TMS Therapy Now Covers Adolescents

Neuronetics' NeuroStar® TMS Therapy Now Covers Adolescents

Neuronetics Expands NeuroStar® TMS Therapy Coverage

Neuronetics, Inc. (NASDAQ: STIM), renowned for its innovative medical technology, has made waves by expanding its NeuroStar Advanced Therapy coverage to adolescents aged 15 and older. This exciting development, recently announced, will provide much-needed support for young individuals battling depression.

TRICARE Coverage Enhancements

TRICARE, primarily covering active and retired military service members and their families, has updated its policy to include TMS coverage for teenagers. This proactive measure reflects a growing recognition of the mental health challenges that adolescents face today. The policy is effective immediately, representing a significant advancement in mental health care for families associated with the military.

Impact of Military Life on Mental Health

Military life can impose unique pressures, affecting not just service members but also their children. Geoffrey Grammer, Chief Medical Officer of Neuronetics and retired U.S. Army Colonel, emphasizes the importance of this policy change. The expansion allows the children of military personnel access to effective mental health treatments, providing vital support during challenging times.

The Importance of TMS in Treating Depression

With an alarming 4.3 million adolescents in the U.S. impacted by major depression, the need for effective treatments is more pressing than ever. Depression can hinder various aspects of a teenager's life, including academic performance and relationships. NeuroStar TMS therapy offers a safe and effective non-pharmaceutical treatment option. It's particularly important as it does not require prior medication failures, making it a first-choice option for treating these young patients.

Clinical Outcomes and Insurance Coverage

The FDA cleared NeuroStar TMS for adolescent patients back in 2024, and since then, its coverage has expanded to include various insurance providers. This includes major players like Evernorth Health Services, BlueCross BlueShield Health Care Service Corporation, and Humana, ensuring that more young people have access to this transformative treatment.

Neuronetics' Commitment to Mental Health

Not only is Neuronetics a pioneer in TMS therapy for adolescents, but it also boasts a dedicated health policy team that collaborates with providers and insurers. Their goal is to advocate and facilitate access to mental health treatments for all patients, especially the underrepresented youth demographic. This commitment showcases Neuronetics' dedication to enhancing the lives of those suffering from mental health disorders.

About Neuronetics and NeuroStar

Neuronetics operates several Greenbrook TMS Inc. centers throughout the United States, where they offer NeuroStar Advanced Therapy for various mental health disorders. Their treatments are backed by a wealth of clinical data, further solidifying their position as leaders in the neurohealth industry. They serve over 60,000 patients, delivering more than 2 million treatments to date.

Partnering for Better Solutions

As Neuronetics continues to innovate and expand its services, it remains focused on overcoming the barriers to effective mental healthcare. Their collaboration with insurers to provide coverage for TMS therapy exemplifies their philanthropic goal of making advanced healthcare accessible to all while respecting the sacrifices of military families.

Frequently Asked Questions

What is NeuroStar TMS Therapy?

NeuroStar TMS Therapy is a non-invasive treatment designed to alleviate symptoms of major depressive disorder using transcranial magnetic stimulation.

Who is eligible for the new TRICARE coverage?

The updated TRICARE policy now includes adolescents aged 15 and older who are beneficiaries of the TRICARE program.

How does TMS Therapy work?

TMS therapy involves using magnetic fields to stimulate nerve cells in the brain, which can improve mood and alleviate depressive symptoms.

Is NeuroStar TMS safe for adolescents?

Yes, NeuroStar TMS has been deemed safe and effective for treating adolescents aged 15-21 based on clinical studies.

What should families do to access TMS treatment?

Families should consult with their healthcare provider to determine if NeuroStar TMS therapy is appropriate and begin the coverage process through TRICARE.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 115

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 43

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 55

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 123

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 77

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 114

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 147

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
MassMedia's Two PRSA Wins Put Campaign Strategy in Focus

Updated Category News Views 100

A pair of trophies is nice; the underlying work matters more. MassMedia picked up two honors at the 2026 PRSA Las Vegas Valley Chapter Pinnacle Awards, presented October 28 at Siena Golf Club. One was a Pinnacle Award in Community Relations for its Safe Teen Driving work with Sam & Ash Injury Law. The other was an Award of Excellence in Reputation and Brand Management for...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 100

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Furniture.com Launches $1,500 Giveaway for Back-to-School Fun

Updated Category News Views 154

Exciting Giveaway from Furniture.com Just in Time for School The online marketplace, Furniture.com, is inviting new social media followers to participate in an exciting giveaway allowing one lucky winner to receive a $1,500 gift card. This giveaway is perfect for anyone looking to enhance their living spaces, such as dorms, home offices, or children's rooms. Transforming...

Continue Reading
Kraken Robotics Achieves Unprecedented Growth in Q3 2025

Updated Category News Views 369

Kraken Robotics Inc. Reports Stellar Q3 2025 Results Kraken Robotics Inc. (TSXV: PNG, OTCQB: KRKNF) has recently released its financial results for Q3 2025, showcasing a remarkable growth trajectory. The company reported consolidated revenue of $31.3 million, marking a significant 60% increase from $19.6 million in the same quarter last year. This surge in revenue can be...

Continue Reading
NVIDIA Innovates AI for Robotics and Autonomous Solutions

Updated Category News Views 337

NVIDIA Enhances Robotics and Automation with New AI Models NVIDIA Corp (NASDAQ: NVDA) is making waves in the semiconductor landscape with its latest advancements in artificial intelligence (AI). With a staggering revenue exceeding $113 billion, NVIDIA has announced innovative generative AI models aimed at improving its Omniverse platform. This initiative is focused on...

Continue Reading
Takeda's ENTYVIO: Transforming IBD Treatment and Market Growth

Updated Category News Views 590

ENTYVIO's Impact on IBD Treatment Takeda Pharmaceutical continues to enhance patient care with ENTYVIO, a gut-selective biologic designed specifically for inflammatory bowel disease (IBD) management. With the recent introduction of a subcutaneous formulation, ENTYVIO has improved patient convenience, allowing for easier administration at home. This evolution in treatment...

Continue Reading
Join AM Best's Complimentary Webinar on AI Litigation Strategies

Updated Category News Views 43

AM Best Webinar Overview AM Best, a global leader in insurance credit ratings, is excited to announce a complementary webinar titled “Defending Artificial Intelligence Claims.” This informative session aims to delve into the intricate world of AI-related legal challenges. Key Discussion Points The webinar will take place at 2:00 p.m. (EST) and features a panel of...

Continue Reading